Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY

Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy

(2011) Y. L. B. Klaver et al.   ANNALS OF ONCOLOGY

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis

(2011) D Elias et al.   ANNALS OF SURGERY

Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin

(2011) Joerg OW Pelz et al.   BMC CANCER

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

(2011) Jan Franko et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

(2010) Valery E. Lemmens et al.   INTERNATIONAL JOURNAL OF CANCER

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

(2010) Robert T Ripley et al.   Trials

Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?

(2009) Terence C. Chua et al.   ANNALS OF SURGERY

Morbidity and Mortality of 109 Consecutive Cytoreductive Procedures with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Performed at a Community Hospital

(2009) Alexander G. Kerscher et al.   WORLD JOURNAL OF SURGERY

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

(2008) Jim Cassidy et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis

(2008) Joerg O.W. Pelz et al.   JOURNAL OF SURGICAL ONCOLOGY